The public offering includes 781,251 shares of its common stock for $2.56 per share, according to a March 4 news release.
The company said it plans to use proceeds from the offering to support clinical trials, its patent portfolio and general corporate purposes, as well as for working capital.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
